Name: Authors Retract Hydroxychloroquine Study, Citing Concern Over Data
Brand: npr.org
SKU: npr-org-492
Availability: OnlineOnly

critic

Authors Retract Hydroxychloroquine Study, Citing Concern Over Data

preview

Study Showing Hydroxychloroquine Increases Death Risk For COVID-19 Is Retracted : Coronavirus Updates A paper suggesting hydroxychloroquine increases the risk of death for patients with COVID-19 has been retracted by three of its authors because they were not able to verify the data used in the study.A large study of the drug hydroxychloroquine has been by three of its authors. The paper, published in the journal the Lancet last month, concluded that hydroxychloroquine, taken either alone or with an antibiotic, to treat patients with COVID-19 was of no benefit and actually increased a patient's risk of dying. The publication of the study prompted the World Health Organization (WHO) to of hydroxychloroquine. The WHO has now resumed the trial. The Lancet paper analyzed data, purported to be from COVID-19 patients in more than 600 hospitals around the world. The data were collected by a private company called , whose founder, , is a co-author on the study. Concerns were raised about the accuracy of the data and the paper started attracting criticism within days of its publication. In anto the Lancet more than a hundred scientists and clinicians asked the journal to provide details about the data and called for the study to be independently validated. So the Lancet launched an independent review and asked Surgisphere to transfer their complete database for evaluation. Surgisphere agreed to the review, but the third party reviewers told the Lancet that they were not able to access all the data, because the company said this would violate client agreements and confidentiality requirements.It was this failure to independently audit the data that prompted three of the study's authors to retract the paper, saying they "can no longer vouch for the veracity of the primary data sources." The Lancet issued a statement saying it takes issues of scientific integrity "extremely seriously," and there are still many outstanding questions about Surgisphere and the data used in the study. The company issued a statement on its pledging transparency, and says it is working to address all questions about the data it provided.Sponsor Message

Study Showing Hydroxychloroquine Increases Death Risk For COVID-19 Is Retracted : Coronavirus Updates A paper suggesting hydroxychloroquine increases the risk of death for patients with COVID-19 has been retracted by three of its authors because they were not able to verify the data used in the study.A large study of the drug hydroxychloroquine has been by three of its authors. The paper, published in the journal the Lancet last month, concluded that hydroxychloroquine, taken either alone or with an antibiotic, to treat patients with COVID-19 was of no benefit and actually increased a...

public

Jane Greenhalgh

News. Arts & Life. Music & more. This is NPR. 🕵️ Securely send us news tips: http://securedrop.npr.org

npr.org

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Authors Retract Hydroxychloroquine Study, Citing Concern Over Data

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS